As the U.S. stock market reaches new highs, buoyed by investor confidence despite ongoing concerns such as the DOJ probe into Fed Chair Powell, identifying stocks that are trading below their fair value can be particularly appealing. In this environment of record-breaking indices and evolving economic conditions, finding undervalued stocks like Advanced Micro Devices and others could offer potential opportunities for investors looking to capitalize on market inefficiencies.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Valley National Bancorp (VLY)	$11.66	$23.01	49.3%
Perfect (PERF)	$1.72	$3.42	49.8%
Hims & Hers Health (HIMS)	$32.20	$63.39	49.2%
Heritage Financial (HFWA)	$23.85	$46.53	48.7%
Fifth Third Bancorp (FITB)	$48.13	$94.38	49%
Fidelity National Information Services (FIS)	$64.23	$125.99	49%
Dingdong (Cayman) (DDL)	$2.92	$5.71	48.9%
Datadog (DDOG)	$125.50	$248.27	49.4%
CNB Financial (CCNE)	$25.93	$50.53	48.7%
Alpha Metallurgical Resources (AMR)	$240.52	$464.55	48.2%

We're going to check out a few of the best picks from our screener tool.

Advanced Micro Devices (AMD)

Overview: Advanced Micro Devices, Inc. is a global semiconductor company with a market cap of approximately $359.75 billion.

Operations: AMD's revenue segments consist of Client at $9.86 billion, Gaming at $3.63 billion, Embedded at $3.43 billion, and Data Center at $15.11 billion.

Estimated Discount To Fair Value: 32.4%

Advanced Micro Devices is currently trading below its estimated fair value, presenting a potential opportunity for investors focusing on cash flow valuation. Recent strategic collaborations and product launches, such as the partnership with Tata Consultancy Services to scale AI adoption, enhance AMD's position in high-performance computing and AI markets. With earnings projected to grow significantly above market averages, AMD's strong revenue growth outlook further supports its status as potentially undervalued based on cash flows.

Krystal Biotech (KRYS)

Overview: Krystal Biotech, Inc. is a commercial-stage biotechnology company focused on discovering, developing, manufacturing, and commercializing genetic medicines for diseases with high unmet medical needs in the United States, with a market cap of $7.89 billion.

Operations: The company's revenue is primarily derived from its genetic medicines aimed at addressing diseases with significant unmet medical needs, totaling $373.16 million.

Estimated Discount To Fair Value: 47.8%

Krystal Biotech is trading significantly below its estimated fair value of US$559.53, suggesting potential undervaluation based on cash flows. The company recently announced positive interim clinical results for KB407 in cystic fibrosis treatment, which could enhance future cash flows. With earnings and revenue growth forecasted to outpace the US market, Krystal's financial outlook appears robust despite a low projected return on equity of 12.6% in three years.

MP Materials (MP)

Overview: MP Materials Corp. produces rare earth materials in the Western Hemisphere and has a market cap of approximately $11.58 billion.

Operations: The company's revenue is primarily derived from its Materials segment, totaling $185.78 million.

Estimated Discount To Fair Value: 45.6%

MP Materials is trading significantly below its estimated fair value of US$117.27, highlighting potential undervaluation based on cash flows. The company has entered a strategic joint venture with the U.S. Department of War and Maaden to develop a rare earth refinery in Saudi Arabia, enhancing its global footprint and supply chain security. Despite recent losses, MP forecasts profitability by Q4 2025, with revenue growth expected to outpace the US market significantly.

Next Steps

• Explore the 188 names from our Undervalued US Stocks Based On Cash Flows screener here.
• Invested in any of these stocks? Simplify your portfolio management with Simply Wall St and stay ahead with our alerts for any critical updates on your stocks.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.